BACKGROUND: Recent advances in immunofluorescence methodology have made it possible to directly monitor protein localization patterns in germ cells undergoing meiosis. We used this technology to examine the early stages of meiosis in testicular material obtained from men presenting for evaluation at infertility clinics. METHODS: Specifically, we compared meiotic progression, synapsis and recombination in 34 individuals with obstructive azoospermia ('controls') to 26 individuals with non-obstructive azoospermia (NOA) ('cases'). RESULTS: In 9 of the 26 cases, no germ cells were identified, but in the remaining 17, there was at least some progression through meiosis. Most of these individuals appeared to have normal levels of spermatogenic activity, with little evidence of meiotic impairment. However, in three individuals, we observed either complete or partial meiotic arrest associated with abnormalities in synapsis. CONCLUSIONS: This suggests that >10% of cases of unexplained NOA may be attributable to severe meiotic defects. The characterization of these meiotic arrest phenotypes may guide further research into the molecular basis of unexplained infertility.
Introduction
A number of genetic abnormalities that contribute to human male infertility have now been identified, including constitutional chromosome abnormalities involving either aneuploidy or structural rearrangements (Chandley, 1988; Van Assche et al., 1996) , microdeletions of Yq-containing spermatogenesis genes (Krausz et al., 2003) and cystic fibrosis transmembrane regulator (CFTR) mutations that result in congenital absence of the vas deferens (Claustres et al., 2000) . However, most cases of non-obstructive azoospermia (NOA) remain unexplained, and we and others (Martin et al., 2003; Egozcue et al., 2005; Sun et al., 2005a,b) have suggested that many of these are attributable to mutations in genes controlling meiotic synapsis or recombination. There are at least two lines of evidence to support this supposition. First, null mutations have been generated for several mouse meiotic genes, including those involved in the initiation or processing of double-strand breaks into functional chiasmata (e.g. Spo11, Dmc1, Pms2 and Mlh1) (Cooke and Saunders, 2002) , formation of the synaptonemal complex (SC) (e.g. Scp3) (Cooke and Saunders, 2002) or establishment of sister chromatid cohesion (e.g. Rec8 and Smc1β) (Revenkova et al., 2004; Xu et al., 2005) . The meiotic phenotypes of the different null mutant males vary subtly, but meiotic disruption and/or arrest and infertility are invariant features . Although similar meiotic mutations have only rarely been described in humans, presumably, this reflects the fact that null mutants are infrequent and appropriate tests to detect them have not yet been conducted. Second, previous cytogenetic studies of meiosis in infertile males suggest alterations in recombination by comparison with normal males. For example, in analyses of diakinesis-stage preparations, both low chiasma frequency (Micic et al., 1982) and alterations in synapsis (Vendrell et al., 1999) have been linked to male infertility. Also, cases of asynaptic meioses in association with consanguineous matings have been reported (Chaganti et al., 1980) , suggesting an autosomal recessive defect in recombination as the cause of some cases of male infertility. Taken together, these two sets of observations suggest that additional analyses focused on human male meiosis will uncover previously unrecognized genetic causes of male infertility.
Application of recently developed immunofluorescence methodology should aid in this search. That is, by immunostaining material from testicular biopsies, we can now monitor the expression of specific recombination machinery proteins and examine the formation of meiosis-specific structures in meiosis I spermatocytes. Preliminary studies that have used this approach to analyse meiosis in infertile males have been promising. Specifically, different groups have now identified either meiotic arrest phenotypes or significant reductions in meiotic recombination in a proportion of males with NOA (Gonsalves et al., 2004; Judis et al., 2004; Sun et al., 2004 Sun et al., , 2005a ; presumably, mutational analyses of loci involved in synapsis or recombination will uncover the molecular basis for infertility in at least some of these individuals.
As part of ongoing studies of human meiosis, our laboratory has been interested in applying immunostaining technology to the study of human spermatogenesis. For the most part, we have focused on the 'normal' situation, examining meiotic progression, synapsis and recombination in azoospermic individuals whose infertility was unrelated to meiotic errors (e.g. cases of obstructive azoospermia). These analyses have provided initial data on the number and distribution of crossovers in the human male , the relationship between the length of the SC and the number of exchanges (Lynn et al., 2002) and the number and location of synaptic initiation sites on human chromosomes (Brown et al., 2005) . However, these observations have also provided important baseline data for investigations of idiopathic infertility. That is, by comparing results from these 'control' males to males with NOA of unknown origin, it should be possible to examine the contribution of meiotic errors to the genesis of male infertility. In the present report, we summarize initial observations using this approach, comparing meiotic progression and recombination rates in a series of control males to males with NOA or severe oligozoospermia. Our results indicate that, in the vast majority of cases of NOA, meiosis proceeds normally, at least until the first meiotic division. However, in >10% of cases, we observed partial-to-complete meiotic arrest during zygotene or pachytene, providing evidence that meiotic errors are an important contributor to male infertility.
Materials and methods

Study population
Participants were solicited from individuals attending the Urology Department of The University Hospitals of Cleveland or the Glickman Urological Institute of the Cleveland Clinic Foundation for treatment of infertility. In each instance, informed consent was obtained according to protocols approved by the Institutional Review Boards of the participating institutions. Controls (n = 34) were defined as individuals who were diagnosed with known causes of infertility not associated with obvious meiotic defects; that is, previous vasectomy (n = 17), CF or CFTR variants (n = 9), unilateral varicocele (n = 3), testicular tumour (n = 2) and others (n = 3; childhood injury, surgical scarring and unspecified obstructive azoospermia, one case each). In all instances, histological examination revealed active spermatogenesis in most, if not all, seminiferous tubules. Routine karyotypic analyses were conducted on 23 of the controls, and sequence tagged site (STS)-based assays for the detection of Yq microdeletions were conducted on 19 of the controls; no abnormalities were detected on either assay. Results of studies of meiotic recombination on 24 of these individuals have been presented previously .
Cases (n = 26) were defined as individuals with NOA of unknown aetiology. Nine of the 26 had no evidence of germ cells on histological examination or immunostaining analysis and were not further processed. Of these, two had non-mosaic 47,XXY chromosome constitutions (Klinefelter syndrome), one had a Yq microdeletion and the other six were simply described as having Sertoli cell only syndrome. The remaining 17 cases displayed germ cells that progressed at least partway through meiosis I, and these individuals form the basis for the present report. One of the 17 was a mosaic for a ring Y chromosome [46,X,r(Y)(?p11.1?q11.2).ishY(DYZ1+,DYZ3,DXYS129/S153+)[24]/ 45,X[8]; however, no other karyotypic abnormalities or Yq microdeletions were identified in these individuals.
SC preparations and immunostaining
The methods utilized for preparing the surface-spread SC slides and the immunostaining have been described elsewhere but with the following modifications. Following maceration, the testicular tissue was incubated in hypotonic solution for 45 min, and the immunostaining was performed no longer than 20 h after slide preparation. The primary antibodies were rabbit polyclonal antibody against human MLH1 (Calbiochem, San Diego, CA, USA; #PC 56T) and goat antibody raised against rat SCP3 (kindly provided by Dr Terry Ashley); CREST antiserum was kindly provided by Dr Sue Varmuza. The secondary antibodies used were fluorescein-conjugated donkey anti-rabbit, rhodamine-conjugated donkey anti-goat and aminomethylcoumarin-conjugated anti-human (Jackson ImmunoResearch; West Grove, PA, USA). Surface-spread SC preparations were incubated with primary antibodies overnight in a 37°C humid chamber, in antibody dilution buffer (ADB) (10× stock consisted of 10 ml of normal donkey serum (Jackson ImmunoResearch), 3% bovine serum albumin (BSA) [Sigma, St. Louis, MO, USA), 50 ml of Triton X-100, brought to a final volume of 100 ml with phosphate-buffered saline (PBS)], MLH1 diluted 1:75, SCP3 1:50 and CREST anti-sera diluted 1:1000. Slides were washed overnight at 4°C in ADB after an initial 10-min wash in ADB at room temperature. Secondary antibodies were diluted 1:100 and incubated on slides for 90 min at 37°C in ADB. Slides were then washed in PBS for 10 min and treated with Antifade (Bio-Rad; Hercules, CA, USA). Slides were stored in the dark at 4°C.
Fluorescence microscopy, imaging and analysis
The number and location of MLH1 foci in pachytene spermatocytes are known to agree well with results of genetic linkage analyses and analyses of chiasmata in diakinesis-stage spermatocytes and thus appear to reliably localize to sites of exchanges in male meiosis (for review, see Lynn et al., 2004) . Thus, to assess the number of crossovers per cell, we counted the number of MLH1 foci in pachytene spermatocytes. To avoid scoring cells with a partial complement of MLH1 foci (i.e. either because they were just entering or exiting pachytene or because the cells had synaptic defects), we restricted our analyses to normally synapsed cells in which at least the haploid number of MLH1 foci (i.e. 23) was identified (Lynn et al., 2002) . For each individual, we attempted to score at least 50 cells.
Immunostained slides were evaluated on a Zeiss Axiophot epifluorescence microscope and imaged with a CCD camera and computer using Quips Pathvysion smartCapture VP 1.4 software (Digital Scientific).
Results
Meiosis proceeds normally in most individuals with NOA
We analysed meiotic progression and recombination rates in the 34 controls and the 17 individuals with NOA ('cases') whose biopsies contained at least some germ cells. Two of the cases exhibited a complete meiotic arrest and one a partial meiotic arrest, and these are discussed separately below. However, all 34 of the controls and the remaining 14 cases exhibited normal progression through meiotic prophase, with mature spermatozoa being present in all testicular samples. Furthermore, pachytene-stage cells predominated in all analysed controls and cases, with little evidence for variation between the two groups.
We analysed recombination in cases and controls by scoring the number and location of MLH1 foci in pachytene spermatocytes (see Materials and methods). Table I provides a summary of observations on the cases, and Figure 1 shows the distributions of MLH1 foci per cell in controls and cases. For the 34 controls, we analysed a total of 2932 cells; the overall mean number of MLH1 foci per cell was 49.2 ± 4.9, with a range of 30-66 foci per cell. For cases, we analysed 1087 cells from the 14 individuals, with an overall mean of 49.0 ± 5.0 MLH1 foci per cell and a range of 27-67 foci per cell.
We compared recombination levels between the two groups in several ways. First, we simply pooled all data from each of the two groups and compared the overall means using Student's t-test methodology; the difference between the groups was non-significant (P = 0.26). Second, to account for the fact that just two individuals (i.e. Sp380 and Sp1001) accounted for ∼40% of all 'case' group cells, we conducted a second t-test in which the means of each of the 14 cases were compared with the 34 individual means for the control group; the difference between the two groups was not significant (P = 0.115). Finally, to assess the possibility that subtle differences between the two groups might result in slight reductions in MLH1 scores in most cases, we conducted a Mann-Whitney U-test; the difference was not significant (P = 0.09). Thus, using various approaches, we were unable to detect any obvious difference between controls and cases in the total number of exchanges per cell. Similarly, there were no apparent differences between cases and controls in the location of exchanges on the chromosomes or in the number of individual bivalents with 0, 1, 2 or 3 or more exchanges (data not shown). 
A proportion of individuals with NOA exhibit meiotic arrest phenotypes
Of the 17 cases whose tissue samples contained at least some germ cells, three (17.6%) exhibited meiotic arrest phenotypes. In two cases, we were unable to locate immature or mature testicular spermatozoa. Instead, each sample contained apparently normal leptotene and early zygotene cells but no normal pachytene cells; these were replaced by abnormal 'end-stage' cells that were subtly different from case to case. In the third case, we were unable to locate any testicular sperm, but rarely occurring, atypical sperm were identified on histological examination. Each of the three cases (Sp356, Sp411 and Sp1016) is described below; as Sp356 was described in a previous report , only the cellular phenotype is briefly summarized here.
Case 1 (Sp356)
A total of 102 SCP3-positive cells were identified, with 15 scored as being at leptotene and the remaining 87 at zygotene. Representative 'end-stage' cells are shown in Figure 2 ; they contained 46 full-length axial elements, but there was no evidence of transverse filament development and no evidence of any association between homologous chromosomes. Additionally, MLH1 foci were not observed. Thus, meiotic arrest appeared to occur at zygotene, with no evidence for synapsis or subsequent crossing-over between homologs.
Case 2 (Sp411)
This case involved a 28-year-old man who presented for testicular biopsy for azoospermia. Cytogenetic analysis was normal (46,XY), and the assay for a Yq chromosome deletion was negative. Similar to Case 1, no cells were found past the zygotene stage, and there was no evidence for the deposition of MLH1.
Specifically, of 45 SCP3-positive cells, 24 were scored as being at leptotene and 21 at zygotene. However, as is apparent from Figure 3 , the end-stage cells appeared more advanced than those of Case 1. That is, the vast majority of these cells exhibited at least partial synapsis between bivalents, and in a few instances, the cells appeared to have near-normal pachytene configurations. Thus, meiosis appeared to arrest at the zygotene/pachytene boundary, with partial synapsis between homologs but with no evidence for crossing-over between homologs.
Case 3 (Sp1016)
This case involved a 33-year-old man who presented for testicular biopsy for severe oligozoospermia. Routine pathology revealed a maturation arrest with a few seminiferous tubules exhibiting a small number of atypical sperm. Karyotype analysis and Yq chromosome deletion analysis were not done.
In initial studies of meiotic progression in 102 SCP3-positive cells, we identified three categories of cells: 60 appeared to be normal leptotene cells, 17 were normal zygotene cells and 25 were abnormal 'pachytene-like' cells with MLH1 localization but with severe defects in synapsis (Figure 4) . The extent of the synaptic defects was extremely variable, from cells in which synapsis was nearly normal ( Figure 4A ) to cells in which asynaptic 'bubbles' or 'forks' were evident on most, if not all, bivalents ( Figure 4B ). Very little tissue was available in this case, and thus, we were unable to examine additional proteins to aid in specifying the timing of the arrest; however, in most cells, the morphology of the XY bivalent was consistent with an early pachytene-stage cell (Solari, 1980) .
In subsequent studies, we scored MLH1 foci in 50 of the abnormal 'pachytene-like' cells. Surprisingly, the overall number and distribution of exchanges were relatively normal. That is, the mean number of MLH1 foci per cell was 42.0 ± 8.6, reduced by only 15% from the overall mean for controls. Additionally, the foci displayed interference, and as expected from studies of controls, distally located foci predominated (data not shown).
Thus, in this case, meiotic arrest appeared to occur in the zygotene/pachytene boundary or early in pachytene. 'Endstage' cells were characterized by multiple synaptic defects, but the recombination pathway was largely intact, with nearnormal numbers of MLH1 foci. However, although our sample contained no post-pachytene cells, a small number of atypical sperm were identified on histological examination. Thus, in at least some seminferous tubules, a small number of cells were able to escape this arrest and finish meiosis.
Discussion
The purpose of this study was 2-fold. First, in NOA cases in which spermatogenesis proceeded past meiosis I, we wanted to know whether defects in recombination were a common occurrence. If so, it would imply an increased risk of aneuploidy in sperm of such individuals, because abnormalities in recombination are a well-established correlate of human meiotic nondisjunction (Lamb et al., 2005) . Second, we were interested in determining the proportion, if any, of cases of unexplained infertility that were due to complete breakdown of spermatogenesis during meiosis I.
The results for each of the two aims were intriguing. First, our studies of 14 cases in which post-pachytene stages were identified provided remarkably little evidence of meiotic disturbances. Synaptic defects were uncommon, recombination levels were similar to those in controls and testicular sperm were evident in all cases. These results are somewhat surprising, because they are at variance with two recent immunostaining studies of NOA (Table II) . Specifically, both Gonsalves et al. (2004) and Sun et al. (2005a,b) reported significant reductions in recombination in association with NOA, and in cases studied by Martin and colleagues and reported in both articles, synaptic defects were more common in NOA than in controls. The reason for the discrepancy between their reports and ours is not clear but could conceivably reflect methodological differences. That is, in our initial studies of recombination in 'control' males (Lynn et al., 2002) , we arbitrarily restricted our analyses to normally synapsed cells with 23 or more MLH1 foci. We reasoned that this would prevent us from scoring cells that were just entering or exiting pachytene or cells that had severe synaptic defects and provided us the potential to detect at least one MLH1 focus per bivalent. We continued this practice in the present study, because any changes in scoring could have introduced an artefactual difference between cases and controls. Neither (2005a,b) took this approach in their studies, and as a large number of their NOA cases had very low MLH1 scores, the overall means were lower for NOA than the controls. Thus, if we had taken their approach (e.g. scoring MLH1 foci in cells with synaptic defects), it is possible that we also would have identified a significant difference in recombination between cases and controls. However, although this is possible, we think it unlikely. That is, we identified a similarly low level of synaptic defects in our cases and controls, suggesting that we would have excluded a similar proportion of cells in both subject categories. Thus, we think it more likely that other factors (e.g. differences in the sample populations), not methodological differences, are the basis for the among-study variation. Clearly, additional studies will be needed to resolve this discrepancy and to determine the level of impairment in recombination, if any, in individuals with NOA. Second, we identified meiotic arrest phenotypes in 3 of the 26 cases, meaning that >10% of all NOA was attributable to meiotic defects. Furthermore, if cases without evidence of germ cells were excluded, the frequency increased to ∼20% (i.e. 3/17 cases). Importantly, these values are similar to those of the two other recently reported immunostaining studies of NOA (Table II) . Specifically, Gonsalves et al. (2004) analysed 40 cases of NOA and identified two cases with complete arrest at zygotene and two others in which only a few pachytene cells were present; similarly, Sun et al. (2005a,b) reported complete zygotene arrest in 1 of 18 cases of NOA. Taken together, these studies suggest that as many as one in five cases of NOA in which germ cells are present are due to abnormalities in meiotic prophase. This has obvious clinical implications. For example, in instances in which testicular biopsies are ascertained for diagnostic purposes, immunostaining analysis is more likely to uncover the cause of infertility than are other standard tests (e.g. routine karyotyping). Furthermore, in instances in which a complete meiotic arrest is identified on immunostaining and in which multiple regions of the testis are examined without any evidence for spermatogenesis, it seems reasonable to consider options other than ICSI (e.g. donor sperm or adoption).
The cases of meiotic arrest are also instructive with regard to the possible mutational sources of male infertility. That is, the three meiotic arrest phenotypes in our study were similar superficially but on closer examination were clearly distinguishable: one case exhibited no synapsis, one partial synapsis but no MLH1 localization and the third partial synapsis and MLH1 deposition. The first two individuals (Sp356 and Sp411) displayed a complete meiotic arrest because there were no sperm visible in the samples. The third individual displayed a partial meiotic arrest phenotype because a small proportion of cells were able to progress through the 'pachytene checkpoint' (Roeder and Bailis, 2000) to produce sperm, thereby avoiding the arrest and apoptosis seen in models such as Atm-deficient mice (Xu et al., 1996) . This is reminiscent of the subtle differences in meiotic phenotype observed in mice homozygous for different null mutations. Thus, it may be that there is no single major cause of meiotic arrest in human males but rather rarely occurring mutations involving any of a number of different meiotic genes. It will be important to confirm or refute this suggestion on additional series of cases because, if true, it will complicate attempts to determine the underlying molecular causes of male infertility. 
